STE

STERIS plc

NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Inc. L2 · CIK 0001757898
$212.35 +0.05% $20.7B
High Impact Filing (7/10)Congressional Activity (1)
Vol
Market Cap$20.7B
Cap SizeLarge Cap
Analyst ConsensusBuy (67%)
Insider Activity0B / 1S
Insider Net $-$310.3K
SEC Reports6
Congressional2 trades
Exchange NYSE·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. L2·CIK 0001757898·Prev Close $212.24

Recent Activity

Jun 5, 2026 SEC
Daniel A. Carestio, an officer and director of STERIS plc, filed a Form 144 notice of intent to sell 1,374 ordinary shar
144 — Impact 2/10
Jun 4, 2026 SEC
Daniel A. Carestio, an officer and director of STERIS plc, filed a Form 144 notice to sell 3,054 ordinary shares current
144 — Impact 2/10
Jun 3, 2026 Insider
Carestio Daniel A sold 2,619 shares
President and CEO @ $210.19 ($550.5K)
Jun 3, 2026 Insider
Kohler Kenneth E sold 184 shares
SVP & GM, AST @ $210.19 ($38.7K)
Jun 3, 2026 Insider
Fraser Mary Clare sold 311 shares
SVP & Chief HRO @ $210.19 ($65.4K)
May 12, 2026 short_volume
Short Volume: STE — 63.7% short (0.6M / 0.9M)
Short: 553,277 | Exempt: 8 | TRF Vol: 868,259 | Short Ratio: 63.7% | Off-exchange volume (dark pool
May 11, 2026 SEC
STERIS reported fiscal Q4 2026 adjusted EPS of $2.83, slightly above the $2.74 prior year but below the $2.85 consensus
PRESS-RELEASE — Impact 6/10
Apr 30, 2026 Congress
April McClain Delaney buy
$1,001 - $15,000 — House

Price Targets

$256.86 +21.0% upside Strong Buy
Current $212.35 Low $225.00 Median $269.00 High $280.00 7 analysts
$225.00 $280.00

Analyst Ratings

Buy67% buy · 15 analysts
3Strong Buy
7Buy
5Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 13, 2026 Keybanc MAINTAIN Overweight → Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $2.50 $2.44 — $2.58 7% YoY 7
Next Q $2.69 $2.65 — $2.76 9% YoY 7
Current FY $11.15 ▲ +0.6% $11.05 — $11.21 10% YoY 8
Next FY $12.10 $11.61 — $12.34 9% YoY 7

Recent Insider Trades

DateInsiderTypeValue
Jun 3, 2026Carestio DanielF$550.5K
Jun 3, 2026Kohler KennethF$38.7K
Jun 3, 2026Fraser MaryF$65.4K
Jun 3, 2026Tamaro RenatoF$13.5K
Jun 3, 2026Madsen JuliaF$50.2K

Congressional Trades

1 members: 2 buys, 0 sells
MemberPartyTypeAmount
April McClainDBUY$1,001 - $15,000
April McClainDBUY$1,001 - $15,000

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

12 unique insiders with 1 transactions. Net insider value: -$310.3K ($0.00 bought, $310.3K sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 3, 2026Carestio Daniel APresident and CEOF2,619$210.19$550.5K
Jun 3, 2026Kohler Kenneth ESVP & GM, ASTF184$210.19$38.7K
Jun 3, 2026Fraser Mary ClareSVP & Chief HROF311$210.19$65.4K
Jun 3, 2026Tamaro RenatoV.P. & Corporate TreasurerF64$210.19$13.5K
Jun 3, 2026Madsen JuliaSr. VP and GM, Life SciencesF239$210.19$50.2K
Jun 3, 2026Zangerle John AdamSr. VP, Gen Counsel, and Sec.F365$210.19$76.7K
Jun 3, 2026Burton Karen LSr. Vice Pres., CFOF190$210.19$39.9K
Jun 2, 2026Carestio Daniel APresident and CEOA23,736$0.00$0.00
Jun 2, 2026Carestio Daniel APresident and CEOF995$209.76$208.7K
Jun 2, 2026Carestio Daniel APresident and CEOA82,740$0.00$0.00
Jun 2, 2026Burton Karen LSr. Vice Pres., CFOA5,325$0.00$0.00
Jun 2, 2026Burton Karen LSr. Vice Pres., CFOM66$209.76$13.8K
Jun 2, 2026Burton Karen LSr. Vice Pres., CFOA18,564$0.00$0.00
Jun 2, 2026Boulud PierreDirectorA367$0.00$0.00
Jun 2, 2026Breeden Richard CDirectorSELL1,481$209.51$310.3K
Jun 2, 2026Breeden Richard CDirectorM3,781$0.00$0.00
Jun 2, 2026Breeden Richard CDirectorM3,781$71.40$270.0K
Jun 2, 2026Kohler Kenneth ESVP & GM, ASTA2,199$0.00$0.00
Jun 2, 2026Kohler Kenneth ESVP & GM, ASTF66$209.76$13.8K
Jun 2, 2026Fraser Mary ClareSVP & Chief HROA3,009$0.00$0.00
Jun 2, 2026Fraser Mary ClareSVP & Chief HROF591$209.76$124.0K
Jun 2, 2026Fraser Mary ClareSVP & Chief HROA10,492$0.00$0.00
Jun 2, 2026Kohler Kenneth ESVP & GM, ASTA7,668$0.00$0.00
Jun 2, 2026Zangerle John AdamSr. VP, Gen Counsel, and Sec.A4,359$0.00$0.00
Jun 2, 2026Zangerle John AdamSr. VP, Gen Counsel, and Sec.F247$209.76$51.8K
Jun 2, 2026Zangerle John AdamSr. VP, Gen Counsel, and Sec.A15,200$0.00$0.00
Jun 2, 2026McGowan LindseyVP, Chf. Comp. & Quality Offc.F329$209.76$69.0K
Jun 2, 2026Tamaro RenatoV.P. & Corporate TreasurerA750$0.00$0.00
Jun 2, 2026Tamaro RenatoV.P. & Corporate TreasurerF41$209.76$8.6K
Jun 2, 2026Tamaro RenatoV.P. & Corporate TreasurerA2,620$0.00$0.00
Jun 2, 2026McGowan LindseyVP, Chf. Comp. & Quality Offc.A1,155$0.00$0.00
Jun 2, 2026McGowan LindseyVP, Chf. Comp. & Quality Offc.A4,036$0.00$0.00
Jun 2, 2026Majors Cary LSVP and President, HealthcareA4,746$0.00$0.00
Jun 2, 2026Majors Cary LSVP and President, HealthcareF67$209.76$14.1K
Jun 2, 2026Madsen JuliaSr. VP and GM, Life SciencesA2,316$0.00$0.00
Jun 2, 2026Majors Cary LSVP and President, HealthcareA16,548$0.00$0.00
Jun 2, 2026Madsen JuliaSr. VP and GM, Life SciencesF127$209.76$26.6K
Jun 2, 2026Madsen JuliaSr. VP and GM, Life SciencesA8,080$0.00$0.00
Jun 1, 2026Burton Karen LSr. Vice Pres., CFOF99$0.00$0.00
Jun 1, 2026Kohler Kenneth ESVP & GM, ASTF109$0.00$0.00
Jun 1, 2026Majors Cary LSVP and President, HealthcareF768$0.00$0.00
Jun 1, 2026Fraser Mary ClareSVP & Chief HROF673$0.00$0.00
Jun 1, 2026Carestio Daniel APresident and CEOF1,254$0.00$0.00
Jun 1, 2026Tamaro RenatoV.P. & Corporate TreasurerF81$0.00$0.00
Jun 1, 2026Madsen JuliaSr. VP and GM, Life SciencesF208$0.00$0.00
Jun 1, 2026McGowan LindseyVP, Chf. Comp. & Quality Offc.F198$0.00$0.00
Jun 1, 2026Zangerle John AdamSr. VP, Gen Counsel, and Sec.F337$0.00$0.00
Mar 5, 2026FELDMANN CYNTHIA LDirectorM3,098$152.32$471.9K
Mar 5, 2026FELDMANN CYNTHIA LDirectorM3,098$0.00$0.00

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Buy (67% buy). Based on 15 analysts: 3 strong buy, 7 buy, 5 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$256.86 mean target +21.0% upside Strong Buy (3.00)
$225.00 Low $280.00 High
MetricValue
Current Price$212.35
Target Low$225.00
Target Mean$256.86
Target Median$269.00
Target High$280.00
# Analysts7
RecommendationStrong Buy (3.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$2.50 $2.44 $2.58 6.9% +0.4% 2↑ 2↓ $1.5B 7.4% 7
Next Q
2026-09-30
$2.69 $2.65 $2.76 9.0% -0.1% 3↑ 2↓ $1.6B 6.7% 7
Current FY
2027-03-31
$11.15 $11.05 $11.21 9.6% +0.6% 3↑ 3↓ $6.4B 7.2% 8
Next FY
2028-03-31
$12.10 $11.61 $12.34 8.5% -0.3% 1↑ 3↓ $6.8B 6.5% 7

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$2.501
7d ago$2.492+0.009
30d ago$2.492+0.009
60d ago$2.517-0.015
90d ago$2.517-0.015
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 13, 2026 Keybanc MAINTAIN Overweight Overweight

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20263750067%
May 1, 20263750067%
Apr 1, 20263750067%
Mar 1, 20263650064%
Feb 1, 20263650064%
Jan 1, 20263640069%
Strong BuyBuyHoldSellStrong Sell
1 members of Congress traded this stock: 2 buys, 0 sells.

Congressional Trades

DateMemberPartyChamberTypeAmountAssetDisclosed
Apr 30, 2026April McClain DelaneyDHOUSEBUY$1,001 - $15,000Steris PLCMay 7, 2026 (8d)
Feb 6, 2026April McClain DelaneyDHOUSEBUY$1,001 - $15,000Steris PLCMar 11, 2026 (34d)

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 12, 2026
short_volume
Short Volume: STE — 63.7% short (0.6M / 0.9M)
Short: 553,277 | Exempt: 8 | TRF Vol: 868,259 | Short Ratio: 63.7% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_interest
FTD: STE — 13,354 shares ($2.7M) failed to deliver
Settlement: 20260512, Price: $201.85, FTD Value: $2,695,504.9, STERIS PLC ORD SHS(IRL)
May 11, 2026
earnings
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
<p>DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its f
May 11, 2026
earnings_calendar
STE Q4 2026 Earnings After Market Close — 2026-05-11
May 11, 2026
dark_pool
Dark Pool: STE — 1.9M shares, 45,626 trades
Week starting 2026-05-11. Total ATS volume: 1,944,059 shares across 45,626 trades.
May 7, 2026
announcement
STERIS Appoints Pierre Boulud to Board of Directors
<p>DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026
May 5, 2026
dividend
STERIS Announces Dividend of $0.63 per share
<p>DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distr
May 4, 2026
dark_pool
Dark Pool: STE — 0.9M shares, 33,475 trades
Week starting 2026-05-04. Total ATS volume: 884,945 shares across 33,475 trades.
Apr 27, 2026
dark_pool
Dark Pool: STE — 1.0M shares, 33,067 trades
Week starting 2026-04-27. Total ATS volume: 974,648 shares across 33,067 trades.
Apr 21, 2026
earnings
STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
<p>DUBLIN, IRELAND, April 21, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a confer
Apr 20, 2026
dark_pool
Dark Pool: STE — 1.0M shares, 27,569 trades
Week starting 2026-04-20. Total ATS volume: 973,820 shares across 27,569 trades.
Apr 13, 2026
dark_pool
Dark Pool: STE — 1.1M shares, 36,321 trades
Week starting 2026-04-13. Total ATS volume: 1,079,777 shares across 36,321 trades.
Apr 6, 2026
dark_pool
Dark Pool: STE — 0.7M shares, 22,995 trades
Week starting 2026-04-06. Total ATS volume: 674,269 shares across 22,995 trades.
Mar 30, 2026
dark_pool
Dark Pool: STE — 0.9M shares, 28,020 trades
Week starting 2026-03-30. Total ATS volume: 900,676 shares across 28,020 trades.
Mar 23, 2026
short_volume
Short Volume: STE — 58.6% short (0.3M / 0.5M)
Short: 305,787 | Exempt: 1,246 | TRF Vol: 521,618 | Short Ratio: 58.6% | Off-exchange volume (dark pool + OTC)